Su Yan

1.5k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Su Yan is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Su Yan has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Su Yan's work include CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Su Yan is often cited by papers focused on CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Su Yan collaborates with scholars based in United States, China and Australia. Su Yan's co-authors include Liu C, Jingyi Xiang, Pei Wang, Mei Song, Renier J. Brentjens, Sarwish Rafiq, Oladapo Yeku, Xiaojing Ma, Dylan J. Drakes and Dayenne G. van Leeuwen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.

In The Last Decade

Su Yan

12 papers receiving 989 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

2018 628 citations Sarwish Rafiq, Oladapo Yeku et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Su Yan United States	9	755	378	349	235	196	12	1.0k
John P. Murad United States	12	783 1.0×	341 0.9×	303 0.9×	326 1.4×	265 1.4×	22	1.1k
Dashnamoorthy Ravi United States	20	283 0.4×	128 0.3×	501 1.4×	96 0.4×	41 0.2×	51	961
Yibing Xu China	15	401 0.5×	425 1.1×	438 1.3×	95 0.4×	53 0.3×	26	1.0k
Lijun Zhao China	14	406 0.5×	226 0.6×	319 0.9×	86 0.4×	77 0.4×	22	837
Sijie Wang China	11	269 0.4×	129 0.3×	149 0.4×	109 0.5×	79 0.4×	20	487
Zhaokai Zhou China	13	259 0.3×	181 0.5×	281 0.8×	94 0.4×	23 0.1×	63	657
Sara Caratelli Italy	11	281 0.4×	215 0.6×	154 0.4×	76 0.3×	36 0.2×	15	495
Baoxiang Guan United States	13	537 0.7×	335 0.9×	588 1.7×	31 0.1×	64 0.3×	20	1.1k
Joe Jiang Zhu Australia	17	264 0.3×	142 0.4×	285 0.8×	74 0.3×	60 0.3×	31	632
Antao Chang China	19	390 0.5×	294 0.8×	617 1.8×	51 0.2×	32 0.2×	38	1.1k

Countries citing papers authored by Su Yan

Since Specialization

Citations

This map shows the geographic impact of Su Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Yan more than expected).

Fields of papers citing papers by Su Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Yan. The network helps show where Su Yan may publish in the future.

Co-authorship network of co-authors of Su Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Su Yan. A scholar is included among the top collaborators of Su Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Yan. Su Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Li, Xueqin, Su Yan, Na Li, Fengru Zhang, & Nan Zhang. (2021). Berberine Attenuates MPP+-Induced Neuronal Injury by Regulating LINC00943/miR-142-5p/KPNA4/NF-κB Pathway in SK-N-SH Cells. Neurochemical Research. 46(12). 3286–3300. 29 indexed citations

2.

Sharma, Sai Kiran, Thapi D. Rao, Kimberly J. Edwards, et al.. (2020). Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation. Nuclear Medicine and Biology. 86-87. 9–19. 5 indexed citations

3.

Lü, Shiyou, et al.. (2019). Crocin inhibits proliferation and induces apoptosis through suppressing MYCN expression in retinoblastoma. Journal of Biochemical and Molecular Toxicology. 33(5). e22292–e22292. 18 indexed citations

4.

Rafiq, Sarwish, Oladapo Yeku, Terence J. Purdon, et al.. (2018). Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nature Biotechnology. 36(9). 847–856. 628 indexed citations breakdown →

5.

Ahmed, Mahiuddin, Andrés López‐Albaitero, Dmitry Pankov, et al.. (2018). TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI Insight. 3(4). 34 indexed citations

6.

Cui, Yong, et al.. (2018). Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression. Chemotherapy. 63(5). 293–300. 20 indexed citations

7.

Liu, Dong, Bo Tang, Aoshuang Xu, et al.. (2018). MicroRNA‑324‑5p suppresses the migration and invasion of MM cells by inhibiting the SCFβ‑TrCP E3 ligase. Oncology Letters. 16(4). 5331–5338. 8 indexed citations

8.

Yan, Su, et al.. (2018). Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation. Toxicology Research. 7(5). 907–912. 16 indexed citations

9.

Rafiq, Sarwish, Oladapo Yeku, Terence J. Purdon, et al.. (2017). Enhancing CAR T Cell Anti-Tumor Efficacy through Secreted Single Chain Variable Fragment (scFv) Immune Checkpoint Blockade. Blood. 130(Suppl_1). 842–842. 6 indexed citations

10.

Liu, Hong, Yiyang Xu, Jingyi Xiang, et al.. (2016). Abstract 2299: ET1402L1-CART, a T cell therapy targeting the intracellular tumor antigen AFP, demonstrates potent antitumor activity in hepatocellular carcinoma models. Cancer Research. 76(14_Supplement). 2299–2299. 1 indexed citations

11.

Dao, Tao, Dmitry Pankov, Andrew Scott, et al.. (2015). Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. 33(10). 1079–1086. 126 indexed citations

12.

Rao, Reena, Reyadh Redha, Ines Macias‐Perez, et al.. (2007). Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo. Journal of Biological Chemistry. 282(23). 16959–16968. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact